Counter-propagation neural networks using 11 descriptors provide high accuracy for predicting and classifying hERG channel blockers, particularly in the 1-10 micromolar IC50 range.
Counter-propagation neural networks were used to develop computational models for classification and prediction of human ether-a-go-go-related-gene (hERG) potassium channel blockers. The data set used includes 285 compounds taken from literature sources and two sets of 2D molecular descriptors, one is based on 32 P_VSA descriptors derived from moe and the other comprises 11 descriptors retrieved by a feature selection method. The counter-propagation neural networks with a 3-dimensional output layer combined with a set of 11 hERG relevant descriptors showed best performance, especially in classifying compounds in the middle-activity class (hERG IC(50) = 1-10 microm). The total accuracy values obtained for training and test sets are 0.93-0.95 and 0.83-0.85, respectively. In each activity class (low, medium, high), 'Goodness of Hit lists' GH scores archived range from 0.89 to 0.97 for the training set and from 0.74 to 0.87 for the test set. This model thus provides possible strategies for improving the performance of predicting and classifying compounds having hERG IC(50) in the range of 1-10 microm.
No takes yet. Share an insight, caveat, or question.
Thai et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: